109,,,,,,,,,,,,,,,,, 1 1 3206060 2 1500000 C15 03 03 150 2007C13003 2007 2010 2() 0() 12001103 2003-01-01 2011-06-01 2012703400010063-1 -
1000 NSCLCNSCLC 85% 550-660 16500-19800 130 11800 10 27 """""""863 " 2011 8 200 500 6000 9 1.5 2012 3 """"- IV 2011 1 2000 10-2 -
1200 1.1 "" IV EGFR EGFR TKI EGFR Iressa Tarceva 2005 2006 NSCLC EGFR NSCLC Iressa Tarceva Iressa Tarceva 550 /16500 / 660 /19800 / Iressa Tarceva EGFR Icotinib Hydrochloride 1.1 Tarceva Iressa FDA Iressa Tarceva 2010 4 2011 6 7 8 12 "" 9 1.5 2012 3 7000 "" 6 6 " " 2012 1500 1-3 -
1200 PCT 2005 ""2006 ""863 2008 "" 2011 "" 2005 2006 IIIIII III 3 III ASCOWCLC 2011 8 12 "" - 4 -
2011 2010 2009 1. 9,163.6 695.8 814.8 0.0 0.0 0.0 0.0 0.0 0.0 2. 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3. 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4. 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5. 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6. 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9,163.6 695.8 814.8 0.0 0.0 0.0 0.0 0.0 0.0-5 -
() () () 1. 2011-2012 2. 2011-2012 3. 2011-2012 4. 2011-2012 5. 2011-2012 6. 2011-2012 - 6 -
1 2 3-7 -
110104196502100057 1965-02-01 1999-01-01 010667869691 589 311100 yinxiang.wang@betapharma.com.cn 13311237800 863 2003-01-01 2011-06-01 300 2002 EGFR BPI-2009H 2002 2006 2011 6 90% - 8 -
- 9 -
057186130266 057189266822 13957198612 057189266028 18805712295 589 tongjia1112@hotmail.com 311100 300 2005 2006-27 2011 6 7 8 6-10 -
- 11 -
150-12 -
- 13 -
- 14 -